Comparison of effectiveness of local corticosteroid injection with autologous blood injection in the treatment of Lateral epicondylitis

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT138711191658N1

Enrollment

Registered

2009-04-05

Start date

2007-09-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lateral Epicondylitis. Lateral Epicondylitis

Interventions

Intervention 1: Single local injection of Methyl Prednisolone (20mg) and Lidocaine 2%(1cc). Intervention 2: Local injection of 2cc of autologous blood with 1cc of lidocaine2%.

Treatment - Drugs

Single local injection of Methyl Prednisolone (20mg) and Lidocaine 2%(1cc)

Local injection of 2cc of autologous blood with 1cc of lidocaine2%

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria:new episode of disease, severe limitation of activity, pain in lateral epicondyle on working, maximum tenderness at ECRB muscle near lat epicondyle(10-15 mm distance), positive coffee test, presence of tenderness distal to lateral epicondyle Exclusion criteria:history of inflammatory diseases. pregnancy or lactation, history of surgery for the present problem, articular deformity, steroid injection(during last 3 month), history of trauma to elbow, use of brace, recieving NSAID

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain of upper limb during 24 hr prior to intervention. Timepoint: Before intervention ,1 and 2 month(s) after intervention. Method of measurement: VAS.;Upper limb function in 24 hr prior to intervention. Timepoint: Before intervention ,1 and 2 month(s) after intervention. Method of measurement: Quick DASH.;Maximum pain in powerful grip. Timepoint: Before intervention ,1 and 2 month(s) after intervention. Method of measurement: VAS.;Pain threshold on examination site. Timepoint: Before intervention ,1 and 2 month(s) after intervention. Method of measurement: Algometer.;Maximum power of hand grip. Timepoint: Before intervention ,1 and 2 month(s) after intervention. Method of measurement: Dynamometer.;Upper limb function on manual works. Timepoint: Before intervention ,1 and 2 month(s) after intervention. Method of measurement: Modified Nirschl stage.	—

Measure

Time frame

Pain of upper limb during 24 hr prior to intervention. Timepoint: Before intervention ,1 and 2 month(s) after intervention. Method of measurement: VAS.;Upper limb function in 24 hr prior to intervention. Timepoint: Before intervention ,1 and 2 month(s) after intervention. Method of measurement: Quick DASH.;Maximum pain in powerful grip. Timepoint: Before intervention ,1 and 2 month(s) after intervention. Method of measurement: VAS.;Pain threshold on examination site. Timepoint: Before intervention ,1 and 2 month(s) after intervention. Method of measurement: Algometer.;Maximum power of hand grip. Timepoint: Before intervention ,1 and 2 month(s) after intervention. Method of measurement: Dynamometer.;Upper limb function on manual works. Timepoint: Before intervention ,1 and 2 month(s) after intervention. Method of measurement: Modified Nirschl stage.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Marzieh Kazemi

Army University of Medical Scinces, 501 Hospital

mkazemi77@yahoo.com

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026